For this issue of The Pharmacologist, we’re excited to share the stories of two prominent ASPET members and leaders in the field. In an autobiographical essay, Joan Brown, PhD,
an ASPET member since 1978, writes openly about the guidance she received throughout her education, and how it informed her award-winning career. And Lori Isom, PhD, a society member since 1998, shares in an oral interview how community and collaboration have been crucially important in her groundbreaking research.
ASPET Executive Officer Dave Jackson discusses ASPET’s next annual meeting, and encourages attendees to submit abstracts for their opportunity to be part of the poster hall. The deadline to submit abstracts for consideration is December 3, which also offers submitters the possibility to be considered for oral presentations and awards.
A Conversation with Daniela Salvemini, PhD, FASPET, FNAI
ASPET Member’s Research Leads to Development of Parkinsons’ Drug, ASPET Welcomes New Members
Honoring ASPET members who have passed.
Last year, I was selected for the Eagleton Institute of Politics Graduate Fellowship Program in Politics and Government. As part of this fellowship, I completed an internship with the New Jersey Office of Legislative Services (OLS), the non-partisan staff for the legislature. Stepping into the political sphere after years focused largely on my own research was intimidating, but gave me insight into local government that I would never have thought to pursue. As a trainee, I had a limited view of the type of work available to scientists in government and how their skills could be utilized in a more policy-forward role. My experience working with OLS opened my eyes to career paths I hadn’t considered, particularly in local government.
In Industry Insights, members of ASPET’s Industry Science Committee discuss the intersection of pharmacology and industry, private sector highlights, and how the industry and membership can support each other.
The Partnerships Committee recently launched a new partnership with the Indian Pharmacological Society (IPS). On behalf of the Partnerships Committee, a sub-committee consisting of Alicja Urbaniak, PhD, University of Arkansas for Medical Sciences; Adam Lauver, PhD, Michigan State University; Fadi Khasawneh, PhD, Texas A&M University; and Yurong Lai, PhD, Gilead Sciences, worked on this partnership. The partnership will kick off with a joint Focus on Pharmacology webinar, “Emerging Trends in Translational Pharmacology: From Drug Discovery to Precision Therapeutics,” on December 16, 2026, from 12 to 1 pm ET. The webinar will be chaired by Dr. Melissa Barker-Haliski, an associate professor at the University of Washington School of Pharmacy. Speakers from both societies will compare approaches to translating discoveries into patient-matched treatments. Representing ASPET, Dr. Lori Isom, Professor and Chair of Pharmacology at the University of Michigan, will present “ASO-Mediated Modulation of Poison Exons to Address Dravet Syndrome.” Representing IPS, Dr. Mukesh Navarre, Associate Dean of Research and Head of the School of Pharmaceutical Sciences at Delhi Pharmaceutical Sciences and Research University (DPSRU) in New Delhi, India, will present “Translational Cardiometabolic Pharmacology: From Molecular Targets to Precision Therapeutics.” This event is free and open to both members and non-members.
A showcase of early-career scientists—what drives them and why pharmacology is important to them.




